Visalytics
Visalytics
approved EB-2 (NIW)

Pediatrics Resident

Biotechnologies · Greece · 2023-02-22

Processing Time
14 days
Decision Date
2023-02-22
Location
District of Columbia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to research the genetic basis and molecular pathogenesis of pediatric disorders and schizophrenia. His work focuses on identifying genetic mutations to develop novel diagnostic methods and targeted therapeutic treatments for rare genetic conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses pediatric morbidity and rare genetic disorders, which are common causes of illness in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D., has 4 years of experience, and has secured funding from prestigious institutions like the NIH.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's unique ability to develop diagnostic tools that lower healthcare costs makes his presence beneficial to the U.S. national interest.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in human genetics, 9 peer-reviewed journal articles, and 162 citations. Evidence included 4 expert recommendation letters, 4 peer reviews, and funding from the National Institute of General Medical Sciences and the National Institute of Mental Health, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Doctor

Healthcare · Israel

WeGreened EB-2 (NIW) approved
Ohio 56 days 2024-12-17
The petitioner proposes to advance the understanding of complex genetic disorders through the development of innovative genetic engineering models and tailored drug design methodologies. This work specifically focuses on investigating somatic mutations in the brains of individuals with Alzheimer’s disease to identify new pathways for diagnosis and therapeutic intervention. The endeavor aims to support the medical community in treating neurodegenerative processes and syndromic autism.
View Case

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
108 days 2022-03-21
The petitioner proposes to continue his research investigating the molecular mechanisms behind genetic disorders, inflammation-associated disorders, and cancers. This work aims to facilitate the development of novel treatments and deepen the scientific understanding of these conditions to provide new therapeutic avenues.
View Case

Researcher

Research and Development · Nepal

WeGreened EB-2 (NIW) rfe approved
Missouri 327 days 2022-10-06
The petitioner proposes to continue her research on analyzing the genetic networks underlying Alzheimer’s disease. Her work focuses on developing early diagnostic procedures and effective treatments for neurodegenerative diseases.
View Case

Scientist

Research and Development · Czech Republic

WeGreened EB-2 (NIW) approved
New York 339 days 2022-05-23
The petitioner proposes to continue utilizing machine learning, statistical genetics, and bioinformatics software to investigate the genetic risk factors driving neuropsychiatric and neurological diseases such as schizophrenia, bipolar disorder, and Alzheimer’s disease. The work aims to provide the scientific community with improved tools to characterize these conditions and support the development of advanced treatments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Greece

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 14 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Greece All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist